Wuhan Easy Diagnosis Biomedicine Co.,Ltd. (SHE:002932)
China flag China · Delayed Price · Currency is CNY
14.64
+0.29 (2.02%)
Jul 1, 2026, 3:04 PM CST

Wuhan Easy Diagnosis Biomedicine Company Description

Wuhan Easy Diagnosis Biomedicine Co.,Ltd. engages in the research and development, production, and sale of vitro diagnostic reagents and diagnostic instruments in China.

The company offers external diagnostic testing, third-party medical testing, certification consulting services, and medical information platform construction services, as well as nutrition and health products for immune, gut, reproductive, and sleep health management.

It also provides information software and supporting hardware products. In addition, the company offers blood gas and chemistry analyzers, fluorescence immunoassay analyzers, molecular diagnosis kit, coagulation analysis machine, and automated glycohemoglobin detection machine.

Wuhan Easy Diagnosis Biomedicine Co.,Ltd. was founded in 2008 and is based in Wuhan, China.

Wuhan Easy Diagnosis Biomedicine Co.,Ltd.
CountryChina
Founded2008
IndustryMedical Devices
SectorHealthcare
Employees599
CEOChen Li Li

Contact Details

Address:
East Lake New Technology Development Zone
Wuhan, 430075
China
Phone86 27 6552 3649
Websitemdeasydiagnosis.com

Stock Details

Ticker Symbol002932
ExchangeShenzhen Stock Exchange
Fiscal YearJanuary - December
Reporting CurrencyCNY
ISIN NumberCNE1000033Q7
SIC Code3845

Key Executives

NamePosition
Chen Li LiChairman and GM
Wang YingVice Chairman and Deputy GM
Rui WangDeputy GM, Chief Financial Officer and Board Secretary
Chaohui LiAccounting Supervisor